Paper24255631
Morphologic alteration of metastatic neuroblastic tumor in bone marrow after chemotherapy.
Bae GE and 3 others. Korean J Pathol, 2013. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Morphologic alteration of metastatic neuroblastic tumor in bone marrow after chemotherapy. Papers, record 24255631. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24255631
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Morphologic alteration of metastatic neuroblastic tumor in bone marrow after chemotherapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16628557 | Neuroblastoma in adults: Incidence and survival analysis based on SEER data. | Pediatr Blood Cancer | 2007 | https://conductscience.org/library/papers/16628557 | PubMed |
| 2 | 23483759 | Presence of differentiating neuroblasts in bone marrow is a favorable prognostic factor for bone marrow metastatic neuroblastoma at diagnosis. | Ann Lab Med | 2013 | https://conductscience.org/library/papers/23483759 | PubMed |
| 3 | 1732433 | A population-based study of neuroblastoma incidence, survival, and mortality in North America. | J Clin Oncol | 1992 | https://conductscience.org/library/papers/1732433 | PubMed |
| 4 | 12880980 | Retinoid therapy of high-risk neuroblastoma. | Cancer Lett | 2003 | https://conductscience.org/library/papers/12880980 | PubMed |
| 5 | 19629500 | Neuroblastoma: treatment outcome after incomplete resection of primary tumors. | Pediatr Surg Int | 2009 | https://conductscience.org/library/papers/19629500 | PubMed |
| 6 | 8260817 | Reciprocal Schwann cell-axon interactions. | Curr Opin Neurobiol | 1993 | https://conductscience.org/library/papers/8260817 | PubMed |
| 7 | 23110006 | Clinicopathological analysis of 21 thymic neuroendocrine tumors. | Korean J Pathol | 2012 | https://conductscience.org/library/papers/23110006 | PubMed |
| 8 | 11051140 | Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma. | J Pediatr Surg | 2000 | https://conductscience.org/library/papers/11051140 | PubMed |
| 9 | 22253825 | Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins. | PLoS One | 2012 | https://conductscience.org/library/papers/22253825 | PubMed |
| 10 | 7444198 | Drug-induced differentiation of human neuroblastoma: transformation into ganglion cells with mitomycin-C. | Results Probl Cell Differ | 1980 | https://conductscience.org/library/papers/7444198 | PubMed |
| 11 | 22162143 | Tumor histology during induction therapy in patients with high-risk neuroblastoma. | Pediatr Blood Cancer | 2012 | https://conductscience.org/library/papers/22162143 | PubMed |
| 12 | 3169728 | Prognostic value of histopathology in advanced neuroblastoma: a report from the Childrens Cancer Study Group. | Hum Pathol | 1988 | https://conductscience.org/library/papers/3169728 | PubMed |
| 13 | 14601099 | Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. | Cancer | 2003 | https://conductscience.org/library/papers/14601099 | PubMed |
| 14 | 19047291 | The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19047291 | PubMed |
| 15 | 10491557 | Neuroblastoma maturation by [(131)I] metaiodobenzylguanidine in chemoresistant neuroblastoma. | Med Pediatr Oncol | 1999 | https://conductscience.org/library/papers/10491557 | PubMed |
| 16 | 3368191 | Neuroblastoma: incomplete differentiation on the way to maturation or morphological alteration resembling maturity? | Oncology | 1988 | https://conductscience.org/library/papers/3368191 | PubMed |
| 17 | 1985243 | Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma. | N Engl J Med | 1991 | https://conductscience.org/library/papers/1985243 | PubMed |
| 18 | 23483025 | Morphologic analysis of pulmonary neuroendocrine tumors. | Korean J Pathol | 2013 | https://conductscience.org/library/papers/23483025 | PubMed |
| 19 | 8618605 | Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8618605 | PubMed |
| 20 | 11844067 | Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemoradiotherapy. | Pathol Int | 2001 | https://conductscience.org/library/papers/11844067 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ENO2 | 2026 | PubTator's text mining | https://conductscience.org/library/genes/2026 | NCBI Gene |
| MYCN | 4613 | PubTator's text mining | https://conductscience.org/library/genes/4613 | NCBI Gene |
| NCAM1 | 4684 | PubTator's text mining | https://conductscience.org/library/genes/4684 | NCBI Gene |
| NGF | 4803 | PubTator's text mining | https://conductscience.org/library/genes/4803 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24255631
GET https://conductscience.org/api/papers/v1/24255631/references?page=2